Benign liver lesions: Differentiation by magnetic resonance

European Journal of Radiology

Volumn 32, Issue 1, 1999, Pages 52-60

  Op De Beeck, Bart ^a   Luypaert, Robert ^a   Dujardin, Martine ^a   Osteaux, Michel ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Contrast enhancement; Liver; Liver neoplasms; MR; MR study

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; DIAGNOSTIC RADIOGRAPHY; DISEASES; MEDICAL APPLICATIONS; MEDICAL IMAGING; ONCOLOGY; ULTRASONIC IMAGING;

FOCAL LESIONS; LIVER NEOPLASMS; OPTIMAL HEPATIC IMAGING; PATIENT MANAGEMENT;

MAGNETIC RESONANCE IMAGING;

COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; LIVER ADENOMA; LIVER CYST; LIVER HEMANGIOMA; LIVER NODULE; LIVER TUMOR; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TUMOR DIAGNOSIS;

EID: 0032702007     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(99)00114-X     Document Type: Article

References (36)

1. Semelka R.C., Balci N.C., Op de Beeck B., Reinhold C. Evaluation of a 10-minute comprehensive MR imaging examination of the upper abdomen. Radiology. 211:1999;189-195.
2. Van Beers B., Gallez B., Pringot J. Contrast-enhanced MR imaging of the liver. Radiology. 203:1997;297-306.
3. Dawson P. Contrast agents in magnetic resonance imaging. Eur. J. Radiol. 23:1996;201-204.
4. Edelman R.R., Siegel J.B., Singer A., Dupuis K., Longmaid H.E. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. Am. J. Roentgenol. 153:1989;113-1219.
5. Mahfouz A.E., Hamm B., Wolf K.J. Dynamic gadopentate dimeglumide-enhanced MR imaging of hepatocellular carcinoma. Eur. Radiol. 3:1993;453-458.
6. Wittenberg J., Stark D.D., Forman B.H. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. Am. J. Roentgenol. 151:1988;79-84.
7. Wilcox D.M., Weinreb J.C., Lesh P. MR imaging of a hemorrhagic hepatic cyst in a patient with polycystic liver disease. J. Comput. Assist. Tomogr. 9:1985;183-185.
8. Karhunen P.J. Benign hepatic tumours and tumour like conditions in men. J. Clin. Pathol. 39:1986;183-188.
9. Mirowitz S., Lee J.K.T., Heiken J.P. Cavernous hemangioma of the liver: assessment of MR tissue specificity with a simplified T2 index. J. Comput. Assist. Tomogr. 14:1990;223-228.
10. Lombardo D.M., Baker M.E., Spritzer C.E., Blinder R., Meyers W., Herfkens R.J. Hepatic hemangiomas vs. metastases: MR differentiation at 1.5T. Am. J. Roentgenol. 155:1990;55-59.
11. Hamm B., Thoeni R.F., Gould R.G., Bernardino M.E., Luning M., Saini S., Mahfouz A.E., Taupitz M., Wolf K.J. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology. 190:1994;417-423.
12. Semelka R.C., Brown E.D., Ascher S.M., Patt R.H., Bagley A.S., Li W., Edelman R.R., Shoenut J.P., Brown J.J. Hepatic hemangiomas: a multi-intitutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology. 192:1994;401-406.
13. Mitchell D.G., Saini S., Weinreb J., De Lange E.E., Runge V.M., Kuhlman J.E., Pariski Y., Johnson C.D., Brown J.J., Schnall M. Hepatic metastases and cavernous hemangiomas: distinction with standard-and triple-dose gadoteridol-enhanced MR imaging. Radiology. 193:1994;49-57.
14. Rummeny EJ, Torres CG, Kurdziel JC, Nilsen G, Op de Beeck B, Lundby B. MnDPDP for MR imaging of the liver: results of an independent image evaluation of the European phase III studies. Acta Radiol 1997; 38: 638-642.
15. Vogl T.J., Hammerstingl R., Schwarz W. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest. Radiol. 31(11):1996;696-708.
16. Shortell C.K., Schwartz S.I. Hepatic adenoma and focal nodular hyperplasia. Surg. Gynecol. Obstet. 173:1991;426-431.
17. Colle I., Op de Beeck B., Hoorens A., Hautekeete M. Multiple focal nodular hyperplasia. J. Gastroenterol. 33:1998;904-908.
18. Haggar A.M., Bree R.L. Hepatic focal nodular hyperplasia: MR imaging at 1.0 and 1.5 T. J. Magn. Reson. Imaging. 2:1992;85-88.
19. Vilgrain V., Flejou J.F., Arrive L., Belghiti J., Najmark D., Menu Y., Zins M., Vullierme M.P., Nahum H. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology. 184:1992;699-703.
20. Lee M.J., Saini S., Hamm B., Taupitz M., Hahn P.F., Seneterre E., Ferrucci J.T. Focal nodular hyperplasia of the liver: MR findings in 35 proved cases. Am. J. Roentgenol. 156:1991;317-320.
21. Mahfouz A.E., Hamm B., Taupitz M., Wolf K.J. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology. 186:1993;133-138.
22. Mathieu D., Rahmouni A., Anglade M.C., Falise B., Beges C., Gheung P., Mollet J.J., Vasile N. Focal nodular hyperplasia of the liver: assessment with contrast-enhanced turboFLASH MR imaging. Radiology. 180:1991;25-30.
23. Vogl T.J., Hamm B., Schnell B., McMahon C., Branding G., Lissner J., Wolf K.J. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J. Magn. Reson. Imaging. 3:1993;51-58.
24. Kerlin P., Davis G.L., McGill D.B., Weiland L.H., Adson M.A., Sheedy P.F.D. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology. 84:1983;994-1002.
25. Debaere C, Op de Beeck B, De Maeseneer M, Osteaux M. MR findings of hepatic adenomas in von Gierke glycogen storage disease. Can Assoc Radiol J 1999 (in press).
26. Paulson E.K., McClellan J.S., Washington K., Spritzer C.E., Meyers W.C., Baker M.E. Hepatic adenoma: MR characteristics and correlation with pathologic findings. Am. J. Roentgenol. 163:1994;113-116.
27. Powers C., Ros P.R., Stoupis C., Johnson W.K., Segel K.H. Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics. 14:1994;459-482.
28. Hamm B., Vogl T.J., Branding G., Schnell B., Taupitz M., Wolf K.J., Lissner J. Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients. Radiology. 182:1992;167-174.
29. Hahn P.F., Stark D.D., Weissleder R., Elizondo G., Saini S., Ferrucci J.T. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology. 174:1990;361-366.
30. Vogl T.J., Hammerstingl R., Schwarz W. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology. 198:1996;881-887.
31. Choi B.I., Takayasu K., Han M.C. Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings. Am. J. Roentgenol. 160:1993;1177-1187.
32. Terada T., Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology. 10:1989;851-854.
33. Ohtomo K., Itai Y., Ohtomo Y., Shiga J., Iio M. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. Am. J. Roentgenol. 154:1990;505-507.
34. Sadek A.G., Mitchell D.G., Siegelman E.S., Outwater E.K., Matteucci T., Hann H.W.L. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology. 195:1995;753-756.
35. Rofsky N.M., Weinreb J.C., Bernardino M.E., Young S.W., Lee J.K., Noz M.E. Hepatocellular tumors: characterization with MnDPDP-enhanced MR imaging. Radiology. 188:1993;53-59.
36. Lencioni R., Caramella D., Bartolozzi C., Mazzeo S., Di Coscio G. Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease. Acta Radiol. 35:1994;138-142.